If I am unable to attend my live oral session, can I pre-record a presentation and have this played during the session? No, all oral presentations must be completed during the live session. If you are ...
Oral presentations will be scheduled in one hour time blocks between 8:45 AM and 1:00 PM in the Campus Center and SAU. Presentations will be grouped by theme or topic area. Presenters will be notified ...
Company will provide an overview of the pritelivir clinical development program in two oral presentations including a comprehensive Phase 2 data overviewUpdated safety and pharmacokinetic results of ...
Telitacicept is approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG). A global Phase 3 clinical trial in gMG is currently ...
Delcath Systems (DCTH) “announced the acceptance of an oral presentation on results from the investigator-initiated CHOPIN randomized Phase 2 ...
BioChaperone® is a proprietary platform tailored to solve peptide formulation issues by means of non-covalent molecular complexation. The oral presentation at the PODD (Partnership Opportunities in ...
BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...
Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed ...
Grace Therapeutics (GRCE) announced that results from its Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH were presented at the 2025 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback